Session » Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Epidemiology, Women's Health, Cardiovascular and CNS
-
Abstract Number: 2619
Low Socioeconomic Status (SES) As Measured By Education Is (not) Associated with Worse Outcome in SLE: Data from the 1000 Canadian Faces of Lupus
-
Abstract Number: 2620
Mortality and Survival in Systemic Lupus Erythematosus Patients: Trends in a Spanish Cohort from 1985 to 2013
-
Abstract Number: 2621
Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 2622
Systemic LUPUS Erythematosus in Spanish Males
-
Abstract Number: 2623
Treatment Patterns and Resource Utilization of Systemic Lupus Erythematosus Patients Newly Initiating Standard of Care: United States Commercial and Medicare Supplemental Claims Analysis
-
Abstract Number: 2624
Impact of Provider Specialty on the Diagnosis and Management of Systemic Lupus Erythematosus in the American Indian/Alaska Native Population
-
Abstract Number: 2625
Work Productivity in Systemic Lupus Erythematosus: Relationship with Clinical Features
-
Abstract Number: 2626
Relationship of Socio-Demographic and Disease Factors with Loss-to-Follow-up and Appointment Noncompliance in Indigent Patients with Systemic Lupus Erythematosus
-
Abstract Number: 2627
Comparison of Disease Characteristics and Organ Damage in Patients with Juvenile and Adult-Onset Systemic Lupus Erythematosus in Large Cohort from Turkey
-
Abstract Number: 2628
Risk of Cancer Is Not Increased in Patients with Cutaneous Lupus Erythematosus: A Population-Based Study
-
Abstract Number: 2629
Childhood-Onset and Adult-Onset Systemic Lupus Erythematosus: Distinctions in an Underserved Ethnic Minority Cohort
-
Abstract Number: 2630
An Evaluation of Quality of Life of Patients with Systemic Lupus Erythematosus Attending Rheumatology Clinic in Kenyatta National Hospital, Nairobi, Kenya
-
Abstract Number: 2631
Overall Cause and Cause-Specific Mortality in a Multinational Inception Cohort of SLE
-
Abstract Number: 2632
The Cornerstone to Reasonable Allocation of Health Resource: Valuation of Health Utility in Systemic Lupus Erythematosus
-
Abstract Number: 2633
Factors Associated with Damage Accrual and Survival in Chinese Patients with Systemic Lupus Erythematosus (SLE): A Prospective Cohort Analysis of 747 Patients
-
Abstract Number: 2634
A Signal of Improvement in Lupus Disease Activity at 3 Months Predicts Further Valid Improvement at 6 Months
-
Abstract Number: 2635
Noncalcified Plaque Progression in Systemic Lupus Erythematosus
-
Abstract Number: 2636
Vitamin D Improves Endothelial Function in Patients with Clinically Stable Systemic Lupus Erythematosus (SLE)
-
Abstract Number: 2637
Assessment of Plaque Thickness and Area in Patients with SLE As Measures of Atherosclerosis – Associations with Disease Activity
-
Abstract Number: 2638
The Protective Effects of Statins for Thrombosis in Patients with Systemic Lupus Erythematosus Positive for Antiphospholipid Antibodies
-
Abstract Number: 2639
Coronary-Artery Atherosclerosis in Males with Systemic Lupus Erythematosus
-
Abstract Number: 2640
Prevalence and Predictors of ECG Cardiovascular Abnormalities in Lupus Patients
-
Abstract Number: 2641
Cardiac Magnetic Resonance Imaging in Systemic Lupus Erythematosus
-
Abstract Number: 2642
Risk of Cardiovascular Events in Patients with Cutaneous Lupus Erythematosus: A Population-Based Study
-
Abstract Number: 2643
Angiogenic and Antiangiogenic Factors in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 2644
Carotid Intima-Media Thickness and Plaque in Mexican Mestizos with Systemic Lupus Erythematosus: A Case-Control Study
-
Abstract Number: 2645
Long-Term Efficacy and Safety of Pulse Cyclophosphamide for Neuropsychiatric Systemic Lupus Erythematosus: A Two-Centre Experience
-
Abstract Number: 2646
Mood Disorders in Systemic Lupus Erythematousus (SLE): Results from an International, Inception Cohort Study
-
Abstract Number: 2647
Predictors of Incident Seizure in Systemic Lupus Erythematosus
-
Abstract Number: 2648
Prednisone Is a Risk Factor for Incident Depression in Systemic Lupus Erythematosus
-
Abstract Number: 2649
“Point of Care” Neurocognitive Testing for Neuropsychiatric Systemic Lupus Erythematosis (NPSLE)
-
Abstract Number: 2650
Cognitive Impairment in SLE and Non-Criterion Anti-Phospholipid Antibodies
-
Abstract Number: 2651
Predictors of Therapeutic Outcomes in Patients with Neuropsychiatric Systemic Lupus Erythematosus
-
Abstract Number: 2652
Headache in Patients with Systemic Lupus Erythematosus Is Associated with Reduced Cerebral Grey Matter Volume, but not with Measures of Glial Activation, Anti-NR2-, or Anti-P Antibodies
-
Abstract Number: 2653
Clinical Features in Patients with Anti-Triosephosphate Isomerase Antibody-Positive Neuropsychiatric Systemic Lupus Erythematosus
-
Abstract Number: 2654
Cognitive Function in Systemic Lupus Erythematosus Patients with Past History of Neuropsychiatric Manifestations : A Longitudinal Study
-
Abstract Number: 2655
Cerebral Small Vessel Disease in Systemic Lupus Erythematosus: Histopathological Study
-
Abstract Number: 2656
The Burden of Neuropsychiatric Symptoms in Systemic Lupus Erythematosus: Physician’s and Patient’s Perspectives
-
Abstract Number: 2657
Brain Gray and White Matter Volume Losses and Their Associations with Glucocorticoid Use in Patients with Newly Diagnosed Systemic Lupus Erythematosus (SLE) – a Prospective MR Study
-
Abstract Number: 2658
Cognitive Symptoms and Associated Disease and Non-Disease Related Factors in Patients with Systemic Lupus Erythematosus : A Longitudinal Study
-
Abstract Number: 2659
Neurofilament H Is Associated with White Matter Lesions in Childhood-Onset Systemic Lupus Erythematosus
-
Abstract Number: 2660
Metabolic Syndrome Features Can Influenciate Cognitive Functions and Brain Lesions in Childhood-Onset Systemic Lupus Erythematosus
-
Abstract Number: 2661
Serum Neuronal Biomarkers and Brain Atrophy in Childhood-Onset Systemic Lupus Erythematosus
-
Abstract Number: 2662
Attribution Protocol and Clinical Significance of Neuropsychiatric Manifestations in Childhood-Onset Systemic Lupus Erythematosus
-
Abstract Number: 2663
Sense of Smell, Anti-Ribosomal P Antibodies and Neuropsychiatric Manifestations in Systemic Lupus Erythematosus
-
Abstract Number: 2664
Increased Risk of Hematological Malignancies in Children Born to Women with SLE
-
Abstract Number: 2665
Risk of Hydrocephalus and/or Macrocephaly in Children Born to Mothers with SLE
-
Abstract Number: 2666
Causes of Stillbirths in Women with SLE
-
Abstract Number: 2667
First-Trimester Disease Activity Does Not Predict Pre-Eclampsia in SLE Pregnancy
-
Abstract Number: 2668
Maternal Clinical Characteristics of SLE and Pregnancy: Hopkins Lupus Pregnancy Cohort
-
Abstract Number: 2669
Systemic Lupus Erythematosus and Lactation: Factors Affecting Infant Feeding Choices in Women with SLE
-
Abstract Number: 2670
Premature Delivery in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 2671
Impact of Glucocorticoid Dose on Maternal and Fetal Outcomes in Lupus Pregnancies